Literature DB >> 34905671

SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S.

Piotr Pawłowski1.   

Abstract

An increase in the positive electric charge of SARS-CoV-2 variant Omicron (B.1.1.529) was reported and the electrostatic interaction between the spike protein S and ACE2 receptor was estimated. The results presented here suggest that electrogenic mutations in specific regions of the S protein and the electrostatic force may facilitate viral infection of the host cell.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34905671     DOI: 10.18388/abp.2020_6072

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  9 in total

1.  Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron.

Authors:  Chiranjib Chakraborty; Manojit Bhattacharya; Ashish Ranjan Sharma; Kuldeep Dhama; Sang-Soo Lee
Journal:  Geroscience       Date:  2022-07-13       Impact factor: 7.581

Review 2.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

3.  Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C.

Authors:  Juanjie Tang; Adrienne G Randolph; Tanya Novak; Tracie C Walker; Laura L Loftis; Matt S Zinter; Katherine Irby; Surender Khurana
Journal:  Vaccines (Basel)       Date:  2022-02-10

Review 4.  COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.

Authors:  Attilio Cavezzi; Roberto Menicagli; Emidio Troiani; Salvatore Corrao
Journal:  F1000Res       Date:  2022-01-27

5.  The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far.

Authors:  Md Sohan; Md Jamal Hossain; Md Rabiul Islam
Journal:  J Med Virol       Date:  2022-01-13       Impact factor: 20.693

6.  Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: Current global scenario.

Authors:  Ranjan K Mohapatra; Ashish K Sarangi; Venkataramana Kandi; Mohammad Azam; Ruchi Tiwari; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-01-05       Impact factor: 20.693

Review 7.  SARS-CoV-2, platelets, and endothelium: coexistence in space and time, or a pernicious ménage à trois?

Authors:  Vladimir Y Bogdanov; Vladimir N Khirmanov
Journal:  Vasc Biol       Date:  2022-06-08

Review 8.  Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review.

Authors:  Akash K; Avinash Sharma; Deepak Kumar; Sachin K Singh; Gaurav Gupta; Dinesh K Chellappan; Kamal Dua; Rupak Nagraik
Journal:  J Med Virol       Date:  2022-06-27       Impact factor: 20.693

Review 9.  Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?

Authors:  Manish Dhawan; AbdulRahman A Saied; Saikat Mitra; Fahad A Alhumaydhi; Talha Bin Emran; Polrat Wilairatana
Journal:  Biomed Pharmacother       Date:  2022-08-15       Impact factor: 7.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.